GO:0060435 bronchiole development: Airway Branching, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060435 bronchiole development describes the biological process by which the first cartilage-free airway branches form and mature from the bronchi.
• Bronchioles are the small conducting airways that lack cartilage and are lined by a heterogeneous epithelium that can be modeled with human pluripotent stem cell-derived lung organoids [1,3].
• Single-cell atlases of small airway disease have revealed distinct epithelial cell states in bronchioles that are altered in chronic obstructive pulmonary disease (COPD).
• Aberrant bronchiolization, the appearance of bronchiolar-like epithelium in alveolar regions, is a driver of pulmonary fibrosis and is linked to cell competition.
• Asthmatic bronchioles show epithelial heterogeneity and mucus plugging that contribute to airflow obstruction and status asthmaticus [5,8].
• Bronchiole development and homeostasis can be studied using organoid models, single-cell transcriptomics, and targeted CRISPR screens [1,3,6].
Description
Bronchiole development (GO:0060435) is the biological process whose specific outcome is the progression of a bronchiole from an initial condition to its mature state, beginning with the formation of the bronchiole and ending with the mature structure. A bronchiole is the first airway branch that no longer contains cartilage and is a branch of the bronchi. This process is essential for establishing the conducting airway tree that delivers air to the gas-exchange regions of the lung. Researchers study bronchiole development to understand congenital airway malformations, chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis, where bronchiolar epithelial remodeling is a central pathological feature [2,5,6,7,8]. Human pluripotent stem cell-derived lung organoids have provided a tractable in vitro system to model bronchiole-like structures and to interrogate the cellular and molecular steps of this process [1,3]. Single-cell transcriptomic atlases of small airways have further defined the epithelial heterogeneity of bronchioles in health and disease, offering a reference for developmental and regenerative studies. Because bronchioles are the first cartilage-free airway branches, their development represents a critical transition from the cartilaginous bronchi to the distal gas-exchange region, and defects in this transition are associated with severe respiratory pathology [1,7].
bronchiole development At A Glance
| GO ID | GO:0060435 |
|---|---|
| GO term | bronchiole development |
| Ontology | biological_process |
| Synonym | none |
| Definition | The biological process whose specific outcome is the progression of a bronchiole from an initial condition to its mature state. This process begins with the formation of the bronchiole and ends with the mature structure. A bronchiole is the first airway branch that no longer contains cartilage; it is a branch of the bronchi. |
| Major function | Formation and maturation of the first cartilage-free airway branches that conduct air to the respiratory zone. |
| Related anatomy | Bronchioles are branches of the bronchi and lack cartilage in their walls. |
| Relevant cell types | Bronchiolar epithelium includes basal, club, ciliated, and neuroendocrine cells, with heterogeneity documented in health and disease [6,8]. |
| Disease relevance | Altered bronchiole development or remodeling is implicated in COPD, asthma, and pulmonary fibrosis [2,5,6,7,8]. |
What Is GO:0060435?
GO:0060435 bronchiole development is defined as the biological process whose specific outcome is the progression of a bronchiole from an initial condition to its mature state. This process begins with the formation of the bronchiole and ends with the mature structure. A bronchiole is the first airway branch that no longer contains cartilage; it is a branch of the bronchi. In practical terms, this ontology term captures the developmental events that generate and mature the small, cartilage-free conducting airways of the lung, including their epithelial specification, morphogenesis, and functional maturation.
Why Is bronchiole development Important in Cell Biology?
Bronchiole development is important because bronchioles are the first cartilage-free airway branches and serve as the primary conducting airways for airflow to the gas-exchange region; their proper formation is required for normal lung function. Disruption of bronchiole development or homeostasis is associated with major human respiratory diseases, including COPD, asthma, and pulmonary fibrosis, where small airway remodeling and bronchiolization contribute to disease progression [2,5,6,7,8]. Understanding the cellular and molecular mechanisms of bronchiole development can inform regenerative medicine strategies, disease modeling, and the identification of therapeutic targets for chronic airway diseases [1,3,6].
• Bronchioles are the first cartilage-free airway branches and are essential for conducting air to the respiratory zone.
• Human pluripotent stem cell-derived lung organoids can model bronchiole-like structures, enabling developmental studies in vitro.
• Single-cell atlases of small airway disease have identified distinct epithelial cell states in bronchioles that are altered in COPD.
• Aberrant bronchiolization in the alveoli is a driver of pulmonary fibrosis and involves cell competition mechanisms.
• Asthmatic bronchioles exhibit epithelial heterogeneity and mucus plugging that contribute to airflow obstruction.
• Status asthmaticus, a severe asthma exacerbation, involves small airway dysfunction and is a life-threatening condition.
• Persistent pulmonary fibrosis in mice is accompanied by epithelial remodeling that includes bronchiolar-like changes.
• Bronchiole development research benefits from organoid and single-cell technologies that can be combined with CRISPR screening [1,3,6].
• Understanding bronchiole development may reveal targets for promoting airway regeneration and treating chronic airway diseases [1,6].
• Bronchiole-associated lymphoid tissue (BALT) in some species highlights the immunological role of bronchioles.
What Happens During bronchiole development?
Initiation of bronchiole formation from the bronchi
In simple terms: The bronchi branch into smaller tubes that will become bronchioles, and these new tubes start to form without cartilage.
Bronchiole development begins with the formation of the bronchiole as a branch of the bronchi. This initial step involves the specification of the airway epithelium at the distal ends of the bronchi, where cartilage is absent. Human pluripotent stem cell-derived lung organoids have been used to model the early stages of airway branching and the generation of bronchiole-like structures in vitro. The process is part of the broader program of lung branching morphogenesis, which establishes the conducting airway tree.
Epithelial specification and differentiation
In simple terms: The cells lining the new bronchiole specialize into different types that will carry out specific jobs.
During bronchiole development, the epithelium undergoes specification and differentiation into distinct cell types, including basal, club, ciliated, and neuroendocrine cells. Single-cell transcriptomic studies of human small airways have revealed substantial epithelial heterogeneity in bronchioles, with distinct cell states that can be identified in health and disease. This heterogeneity is also evident in asthmatic bronchioles, where altered epithelial cell states and mucus plugging are observed. The differentiation of these cell types is essential for the mature bronchiole to conduct air and respond to environmental insults [6,8].
Morphogenesis and maturation of the bronchiole
In simple terms: The bronchiole grows and takes its final shape, becoming a mature tube that can carry air.
Following specification, the bronchiole undergoes morphogenesis and maturation to reach its mature structure. This includes the establishment of the airway lumen, the formation of a continuous epithelial lining, and the acquisition of functional properties such as mucus production and ciliary beating. In vitro models using human pluripotent stem cell-derived lung organoids have been used to study the progression of airway development, including the formation of bronchiole-like structures. The maturation of the bronchiole is critical for normal lung function, and defects in this process can lead to respiratory disease [1,7].
Integration with the surrounding mesenchyme and vasculature
In simple terms: The bronchiole develops together with the tissues around it, including blood vessels and support cells.
Bronchiole development does not occur in isolation; it requires interactions with the surrounding mesenchyme and the developing vasculature. These interactions provide signals that guide branching, epithelial differentiation, and maturation. Studies using lung organoids have highlighted the importance of the microenvironment in directing airway development. In disease states such as pulmonary fibrosis, aberrant epithelial remodeling and bronchiolization involve changes in the surrounding tissue that affect bronchiolar-like structures. The integration of the bronchiole with its niche is therefore essential for proper development and function [1,7].
Functional maturation and maintenance
In simple terms: The mature bronchiole is maintained throughout life, and its cells can renew themselves.
Once formed, the bronchiole must be maintained and repaired throughout life. The mature bronchiole contains progenitor cells that can self-renew and differentiate to replace damaged cells. Single-cell studies of small airway disease have identified progenitor populations and their alterations in COPD, providing insights into maintenance and repair mechanisms. In asthma, chronic inflammation and remodeling can disrupt bronchiole homeostasis, leading to mucus plugging and airflow obstruction. Understanding the maintenance of the mature bronchiole is important for developing therapies for chronic airway diseases [6,8].
Key Genes Involved in GO:0060435 bronchiole development
The following genes and proteins have been implicated in bronchiole development, small airway biology, and related diseases based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KRT5 | Basal cell marker in bronchiolar epithelium | Used to identify basal cells in small airway atlases and disease models |
| KRT8 | Epithelial cell marker | Marks luminal cells in bronchiole-like structures and organoids |
| SCGB1A1 | Club cell secretory protein | Marker of club cells in bronchioles; altered in COPD and asthma [6,8] |
| FOXJ1 | Ciliated cell transcription factor | Marks ciliated cells in bronchioles; relevant to mucociliary clearance |
| MUC5AC | Mucin production | Associated with mucus plugging in asthmatic bronchioles |
| MUC5B | Mucin production | Associated with mucus plugging and airway disease |
| TP63 | Basal cell transcription factor | Regulates basal cell identity in bronchiolar epithelium |
| SOX2 | Airway epithelial progenitor marker | Involved in proximal airway development and differentiation |
| SOX9 | Distal airway progenitor marker | Involved in branching morphogenesis and distal airway development |
| NKX2-1 | Lung epithelial transcription factor | Essential for lung development and airway epithelial specification |
| ID2 | Transcription factor | Regulates airway progenitor differentiation |
| HOPX | Alveolar and airway progenitor marker | Used in single-cell studies of small airway disease |
| SFTPC | Surfactant protein C | Marker of alveolar type II cells; relevant to bronchiolization in fibrosis |
| ACTA2 | Smooth muscle actin | Marks myofibroblasts in airway remodeling and fibrosis |
| COL1A1 | Collagen production | Associated with fibrosis and airway remodeling |
| IL13 | Type 2 cytokine | Drives goblet cell metaplasia and mucus production in asthma |
| IL4 | Type 2 cytokine | Promotes allergic airway inflammation and remodeling |
| CCL2 | Chemokine | Recruits monocytes in pulmonary fibrosis and airway remodeling |
How Is bronchiole development Regulated?
Bronchiole development and homeostasis are regulated by a complex interplay of transcription factors, signaling pathways, and cell-cell interactions. Key developmental signals include those that pattern the proximal-distal axis of the lung and specify airway epithelial cell fates. In disease states, aberrant activation of repair and inflammatory pathways can lead to bronchiolization and fibrosis, with cell competition acting as a driver of these changes. Type 2 cytokines such as IL13 and IL4 regulate goblet cell metaplasia and mucus production in asthmatic bronchioles. Additionally, chronic injury can lead to persistent epithelial remodeling, as observed in mouse models of pulmonary fibrosis. The regulation of bronchiole development is therefore tightly linked to both developmental programs and pathological remodeling processes [1,2,7,8].
bronchiole development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCGB1A1 | COPD, asthma; club cell dysfunction | Club cell-specific knockout or overexpression in mouse lung [6,8] |
| MUC5AC | Asthma; mucus plugging | Goblet cell-specific knockout or overexpression |
| MUC5B | Asthma; mucus plugging | Goblet cell-specific knockout or overexpression |
| KRT5 | COPD; basal cell hyperplasia | Basal cell lineage tracing and knockout |
| COL1A1 | Pulmonary fibrosis; collagen deposition | Fibroblast-specific knockout or overexpression [2,7] |
Chronic obstructive pulmonary disease (COPD)
COPD is characterized by small airway disease, including remodeling and loss of bronchioles. Single-cell atlases of small airways in COPD have revealed altered epithelial cell states and gene expression programs that differ from healthy bronchioles. These changes contribute to airflow obstruction and disease progression. Understanding the developmental pathways that maintain bronchiolar epithelium may provide insights into COPD pathogenesis.
Asthma and status asthmaticus
Asthmatic bronchioles exhibit epithelial heterogeneity, goblet cell metaplasia, and mucus plugging, which are hallmarks of airway obstruction. Status asthmaticus is a severe, life-threatening asthma exacerbation that involves small airway dysfunction and can lead to respiratory failure. The study of bronchiole development and epithelial differentiation may inform new therapeutic approaches for severe asthma [5,8].
Pulmonary fibrosis and bronchiolization
Pulmonary fibrosis is a progressive disease characterized by scarring of the lung interstitium and aberrant epithelial remodeling. Bronchiolization, the appearance of bronchiolar-like epithelium in alveolar regions, is a key feature of fibrosis and is driven in part by cell competition. Mouse models of persistent pulmonary fibrosis show epithelial remodeling that includes bronchiolar-like changes. Targeting the pathways that drive bronchiolization may offer therapeutic strategies for fibrosis [2,7].
Bronchiole-associated lymphoid tissue (BALT) and immune responses
Bronchiole-associated lymphoid tissue (BALT) is a component of the mucosal immune system in some species, including Bactrian camels, and is located near bronchioles. BALT can be induced in response to infection or inflammation and may influence airway disease. The study of BALT provides insights into the immunological functions of the bronchiolar microenvironment.
From bronchiole development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of a candidate gene in bronchiole development? | Knockout of the gene in human lung organoids or mouse airway epithelium |
| Does a specific point mutation in a gene cause airway epithelial dysfunction? | Point mutation knock-in in human pluripotent stem cells followed by organoid differentiation [1,3] |
| How does a disease-associated variant affect bronchiole development? | Knock-in of the variant in human lung organoids [1,3] |
| Where is a protein of interest expressed during bronchiole development? | Tagged knock-in (e.g., GFP) in human lung organoids or mouse models |
| What happens when a gene is overexpressed in bronchiolar epithelium? | Overexpression in human lung organoids or mouse airway epithelium [1,6] |
| Which genes are required for bronchiole development? | CRISPR library screening in human lung organoids [1,3] |
How to Study the bronchiole development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Human lung organoid differentiation | Formation of bronchiole-like structures | Modeling bronchiole development in vitro |
| Single-cell RNA sequencing | Transcriptomic profiles of individual cells | Identifying epithelial cell states in bronchioles [6,8] |
| CRISPR knockout in organoids | Loss-of-function effects on bronchiole development | Testing candidate gene function |
| Lineage tracing in mice | Cell fate and contribution to bronchioles | Studying developmental origins |
| Immunofluorescence | Protein localization and expression | Validating cell types in bronchioles |
| Air-liquid interface culture | Epithelial differentiation and function | Modeling bronchiolar epithelium |
| Mucus plugging assays | Mucus production and obstruction | Studying asthma pathology |
| Cell competition assays | Competitive fitness of epithelial cells | Investigating bronchiolization in fibrosis |
Human lung organoid models
Human pluripotent stem cell-derived lung organoids provide a tractable in vitro system to model bronchiole development and disease. These organoids can be generated using defined protocols and can recapitulate aspects of airway branching and epithelial differentiation. They have been used to study progenitor identification and SARS-CoV-2 infection in distal lung. Organoids can be combined with CRISPR gene editing to interrogate gene function during bronchiole development.
Single-cell transcriptomics
Single-cell RNA sequencing (scRNA-seq) has been used to create atlases of small airways in health and disease, revealing epithelial heterogeneity and cell states in bronchioles. This approach can identify rare cell populations and disease-associated changes in gene expression. In asthma, scRNA-seq has been applied to study epithelial heterogeneity and mucus plugging in bronchioles. Single-cell methods are powerful for discovering markers and regulatory programs in bronchiole development [6,8].
Animal models of airway disease
Mouse models of pulmonary fibrosis and airway disease have been used to study epithelial remodeling and bronchiolization. Persistent, progressive pulmonary fibrosis in mice is accompanied by epithelial remodeling that includes bronchiolar-like changes. These models allow for lineage tracing and genetic manipulation to study bronchiole development and disease [2,7]. They complement human organoid studies by providing an in vivo context.
Imaging and histology
Imaging techniques, including immunofluorescence and in situ hybridization, are used to visualize bronchiole structures and protein expression. Histological studies of bronchus-associated lymphoid tissue (BALT) in Bactrian camels have described the structural characteristics of bronchioles and associated lymphoid tissue. These methods are essential for validating findings from transcriptomic and organoid studies.
How CRISPR Can Be Used to Study GO:0060435 bronchiole development
Knockout
CRISPR knockout is used to disrupt candidate genes in human lung organoids or mouse airway epithelium to determine their requirement for bronchiole development. For example, knocking out genes involved in epithelial differentiation can reveal their role in forming bronchiole-like structures. This approach can be combined with single-cell readouts to assess effects on cell states.
Point Mutation
Point mutation knock-in via CRISPR is used to model specific disease-associated variants in genes implicated in bronchiole development or disease. This allows researchers to study the functional consequences of a single nucleotide change on airway epithelial biology [1,3]. Such models are valuable for understanding genetic contributions to COPD, asthma, and fibrosis [6,8].
Knock-in
Knock-in of reporter tags (e.g., GFP) or disease variants enables visualization and functional analysis of proteins in bronchiolar cells. Tagged knock-in in human pluripotent stem cells followed by organoid differentiation can reveal protein localization during bronchiole development. Knock-in of disease variants can model genetic susceptibility to airway diseases.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression is used to increase the expression of candidate genes in bronchiolar epithelium to test sufficiency in driving developmental or pathological changes. Overexpression of mucins such as MUC5AC or MUC5B can induce mucus plugging in models of asthma. Overexpression of fibrotic genes can promote bronchiolization and fibrosis.
How EDITGENE Supports bronchiole development Research
Researchers studying bronchiole development-related genes often need to determine whether a candidate gene is causally involved in airway epithelial differentiation, branching, or disease-associated remodeling. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and knock-in reporters, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for bronchiole development research.
Frequently Asked Questions About bronchiole development
What is GO:0060435 bronchiole development?
GO:0060435 is a Gene Ontology biological process term defined as the progression of a bronchiole from an initial condition to its mature state, beginning with its formation and ending with the mature structure. A bronchiole is the first airway branch that no longer contains cartilage and is a branch of the bronchi.
What genes are involved in bronchiole development?
Genes involved in bronchiole development include transcription factors such as NKX2-1, SOX2, and SOX9, as well as markers of differentiated cell types like SCGB1A1 (club cells), FOXJ1 (ciliated cells), and KRT5 (basal cells). These genes have been identified in studies of lung organoids and single-cell atlases of small airways [1,6].
How are bronchioles different from bronchi?
Bronchioles are the first airway branches that lack cartilage in their walls, whereas bronchi contain cartilage. Bronchioles are branches of the bronchi and are smaller in diameter.
What diseases are associated with bronchiole development?
Diseases associated with bronchiole development and remodeling include chronic obstructive pulmonary disease (COPD), asthma (including status asthmaticus), and pulmonary fibrosis. These conditions involve changes in bronchiolar epithelium, mucus plugging, and bronchiolization [2,5,6,7,8].
How can I study bronchiole development in the lab?
Bronchiole development can be studied using human pluripotent stem cell-derived lung organoids, single-cell RNA sequencing, and animal models of airway disease. CRISPR gene editing can be combined with these models to test gene function [1,3,6].
What are human lung organoids?
Human lung organoids are three-dimensional in vitro structures derived from pluripotent stem cells that recapitulate aspects of lung development and disease, including the formation of bronchiole-like structures.
What is bronchiolization in pulmonary fibrosis?
Bronchiolization is the appearance of bronchiolar-like epithelium in alveolar regions, which is a feature of pulmonary fibrosis and is driven in part by cell competition.
How does asthma affect bronchioles?
Asthma causes epithelial heterogeneity, goblet cell metaplasia, and mucus plugging in bronchioles, leading to airflow obstruction. Severe asthma exacerbations, such as status asthmaticus, can be life-threatening [5,8].
What is the role of single-cell RNA sequencing in bronchiole research?
Single-cell RNA sequencing has been used to create atlases of small airways, revealing distinct epithelial cell states in bronchioles and their alterations in diseases like COPD and asthma [6,8].
Can CRISPR be used to study bronchiole development?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression can be applied in human lung organoids and airway epithelial cells to study gene function in bronchiole development and disease [1,3].
Conclusion
GO:0060435 bronchiole development is a fundamental biological process that governs the formation and maturation of the first cartilage-free airway branches. Research using human lung organoids, single-cell transcriptomics, and animal models has illuminated the cellular and molecular mechanisms of this process and its disruption in diseases such as COPD, asthma, and pulmonary fibrosis [1,2,5,6,7,8]. Continued investigation of bronchiole development will advance our understanding of airway biology and inform regenerative and therapeutic strategies for chronic respiratory diseases.
References
- 1. Miller AJ et al.. 2019. Generation of lung organoids from human pluripotent stem cells in vitro.. Nat Protoc 14(2):518-540 PMID: 30664680
- 2. Redente EF et al.. 2021. Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice.. Am J Respir Cell Mol Biol 64(6):669-676 PMID: 33406369
- 3. Salahudeen AA et al.. 2020. Progenitor identification and SARS-CoV-2 infection in human distal lung organoids.. Nature 588(7839):670-675 PMID: 33238290
- 4. He W et al.. 2019. The distributive and structural characteristics of bronchus-associated lymphoid tissue (BALT) in Bactrian camels (Camelus bactrianus).. PeerJ 7:e6571 PMID: 30881767
- 5. Chen RJ et al.. 2026. Status Asthmaticus.. PMID: 30252326
- 6. Booth S et al.. 2023. A Single-Cell Atlas of Small Airway Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.. Am J Respir Crit Care Med 208(4):472-486 PMID: 37406359
- 7. Warren R et al.. 2024. Cell competition drives bronchiolization and pulmonary fibrosis.. Nat Commun 15(1):10624 PMID: 39639058
- 8. Schworer SA et al.. 2026. Airway epithelial heterogeneity and mucus plugging in asthmatic bronchioles.. Am J Respir Crit Care Med 212(2):209-226 PMID: 40986379
